TransMedics Group, Inc. (TMDX) financials

TransMedics Group, Inc. (TMDX) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, TransMedics Group, Inc. reported revenue of $605M, up 37.1% year over year, net income of $190M, diluted EPS of $4.87 and free cash flow of $134M.

Revenue (fiscal 2025)

$605M

Revenue growth (fiscal 2025)

37.1%

Net income (fiscal 2025)

$190M

Diluted EPS (fiscal 2025)

$4.87

Free cash flow (fiscal 2025)

$134M

TransMedics Group, Inc. files with the U.S. Securities and Exchange Commission under CIK 0001756262, classified as Electromedical & Electrotherapeutic Apparatus.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.